NAS
AUPH icon

Nicolet Advisory Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Nicolet Advisory Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,750
Closed -$166K – 344
2023
Q4 		$166K Sell
19,750
-800
-4% -$6.59K 0.02% 309
2023
Q3 		$148K Sell
20,550
-400
-2% -$3.91K 0.02% 306
2023
Q2 		$212K Buy
20,950
+1,964
+10% +$20.4K 0.02% 289
2023
Q1 		$187K Buy
18,986
+689
+4% +$6.07K 0.02% 273
2022
Q4 		$152K Buy
+18,297
New +$106K 0.02% 231

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nicolet Advisory Services's AUPH Position: Q1 2024 in Review

Nicolet Advisory Services sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 19,750 shares — an estimated $166K sold.

Nicolet Advisory Services first reported a position in AUPH in Q4 2022 and held it in 5 quarters. The position peaked at $212K in Q2 2023. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Nicolet Advisory Services reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Nicolet Advisory Services sold 19,750 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $166K.
  • Nicolet Advisory Services first reported a position in Aurinia Pharmaceuticals in Q4 2022 and held it in 5 quarters.
  • Nicolet Advisory Services's Aurinia Pharmaceuticals position peaked at $212K in Q2 2023.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Nicolet Advisory Services's 13F filing for Q1 2024, filed 10 May 2024.